Publication | Open Access
Operational Standards for CASA Instruments
135
Citations
36
References
1993
Year
FertilityMeasurementReproductive HealthGynecologySemen AnalysisVirtual InstrumentationCalibrationConformance TestingSystems EngineeringMeasurement InstrumentationBiostatisticsInstrumentationPublic HealthLaboratory MedicineSexual And Reproductive HealthPercent MotilityInfertilityAndrologyConventional InstrumentationDesignCasa TechnologyLaboratory AutomationFertility TrackingHuman ReproductionComputer-aided Sperm AnalysisMedicineOperational Standards
CASA, a seven‑year‑old technology with over 120 supporting studies, still suffers from persistent technical issues—such as frame‑rate‑dependent velocity, inaccurate motility counts, and algorithm variability—preventing it from delivering the objective, automated semen analysis it promises, a concern heightened by rising laboratory accuracy and accreditation demands. The authors contend that defining instrument performance standards and fostering collaboration between laboratory medicine and industry are essential to realize CASA’s potential. The review finds that CASA instruments lack standard practices both within and across devices, and professional societies have not adopted or recommended any standards.
Computer-aided sperm analysis (CASA) technology is 7 years old. Over 120 papers have been written that verify the technology or apply it in basic and clinical studies. Most of the technical problems with CASA, such as the dependence of velocity on video frame rate, inaccuracy of count and percent motility for low- and high-concentration specimens, parameter dependence on the number of frames analyzed, sensitivity of the subjective threshold setting, confusion over the presence of debris, and different implementations of algorithms across instruments, still persist. A critical review of the literature reveals that no standard practices are followed within or across instruments. Moreover, no standards have been embraced or recommended by professional societies. Despite its potential to provide objective measurements of specimen and individual sperm parameters, and to automate the laboratory semen analysis, the promise of CASA has not been fulfilled. Unless laboratory medicine defines instrument performance and laboratory standards and co-operates with industry to achieve these goals, CASA technology may remain a research curiosity. This outcome is especially worrisome in the context of increasing requirements for laboratory accuracy, precision, standardization, and accreditation under the Clinical Laboratory Improvement Act of 1988.
| Year | Citations | |
|---|---|---|
Page 1
Page 1